Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Divaltec 750mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Tripada Healthcare Pvt Ltd

Salt Composition

Divalproex (750mg)

Overview Divaltec 750mg Tablet ER

Epileptic seizures and migraine prophylaxis are primary indications for the extended-release 750mg Divaltec tablet. It can also be prescribed, in some cases, for bipolar disorder management, either as monotherapy or in conjunction with other medications. Dosage and frequency are determined individually by your physician to optimize symptom control. Administer this medication at the same time daily, with or without food, for maximum therapeutic benefit; effects typically manifest within two weeks. Consistent adherence to the prescribed regimen is crucial; discontinuation or missed doses can exacerbate the underlying condition and potentially trigger seizures; abrupt cessation is contraindicated. Common, generally mild, adverse effects include nausea, vomiting, dizziness, fatigue, blurred vision, headache, unsteady gait, bruising, and hypothermia. Report persistent or bothersome side effects to your physician. However, seek immediate medical attention should a skin rash or redness develop. Prolonged use may reduce bone density (osteoporosis), increasing fracture risk. Rarely, suicidal ideation or behavior may occur; notify your doctor if depression symptoms emerge. Prior to initiating treatment, inform your physician of any pre-existing heart, kidney, or liver conditions; urinary difficulties; history of depression; or suicidal thoughts. Potential drug interactions exist; comprehensively disclose all current medications to ensure safe co-administration. Consult your doctor before altering Divaltec usage during pregnancy. Alcohol consumption should be avoided due to increased risk of side effects and seizure recurrence. Regular blood monitoring, before and during treatment, is usually necessary to optimize dosage.

Uses of Divaltec 750mg Tablet ER

Managing epileptic seizures and bipolar disorder, plus migraine prevention.

Major Benefits of Divaltec 750mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the 750mg extended-release Divaltec tablet whole; do not break, crush, or chew it. While you can take it with or without food, consistent timing is recommended.

Common Side effects of Divaltec 750mg Tablet ER:

  • Decreased body temperature
  • Dizziness
  • Sleepiness
  • Tremors
  • Paresthesia (tingling or pricking sensation)
  • Anemia (low number of red blood cells)
  • Decreased sodium level in blood
  • Liver injury
  • Gastrointestinal disturbance
  • Hypersensitivity
  • Deafness
  • Urinary incontinence
  • Increase in body weight
  • Pain during periods

How to use Divaltec 750mg Tablet ER:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Divaltec 750mg Extended-Release Tablets can be consumed with or without food, however, consistent daily timing is recommended.

How Divaltec 750mg Tablet ER works:

Epileptic seizures are managed by Divaltec 750mg Extended-Release tablets, an anticonvulsant that reduces overactive neuronal firing in the brain.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Divaltec 750mg extended-release tablets and alcohol can lead to increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Divaltec 750mg tablets pose a confirmed risk to a fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Divaltec 750mg tablets are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.

DrivingDrivingUNSAFE

Extended-release Divaltec 750mg tablets may impair driving ability due to potential adverse reactions.

KidneyKidneySAFE IF PRESCRIBED

Extended-release Divaltec 750mg tablets pose no safety concerns for patients with renal impairment; dosage modification is unnecessary.

LiverLiverUNSAFE

Extended-release Divaltec 750mg tablets are contraindicated for individuals with hepatic impairment and should be omitted. Physician consultation is recommended.

What if you forget to take Divaltec 750mg Tablet ER :

Should you forget to take a Divaltec 750mg Extended-Release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Divaltec 750mg Tablet ER

LabelValue
Chemical Category Derivatives of Aliphatic Carboxylic Acids
Developing Habits No.
Treatment Category Neuroscience, Central Nervous System
Actions Sodium channel-blocking antiepileptic drugs

FAQs on Divaltec 750mg Tablet ER

Always consult your doctor before discontinuing Divaltec 750mg Tablet ER. Withdrawal should be gradual, under medical supervision, to avoid potential side effects such as symptom recurrence, irritability, anxiety, dizziness, or tremors.
Divaltec 750mg Extended-Release tablets may be used to stabilize mood in individuals experiencing rapid mood swings. This effect is achieved by reducing excessive brain activity associated with these fluctuations.
Divaltec 750mg ER tablets can cause weight gain, possibly from increased appetite. Manage your diet and exercise to minimize this risk. Consult your doctor if weight gain is a concern.
Drowsiness is a possible side effect of Divaltec 750mg Tablet ER. Refrain from driving or activities requiring alertness until you understand its impact on you.
Hair loss is a possible, temporary side effect of Divaltec 750mg ER tablets, often linked to dosage. Consult your doctor if this side effect concerns you or continues.
Divaltec 750mg Tablet ER can cause liver damage, particularly within the first six months of treatment. Symptoms may include nausea, vomiting, appetite loss, stomach pain, dark urine, facial swelling, and jaundice (yellowing of skin or eyes). Liver function tests are recommended before starting and regularly during the initial six months, especially for at-risk individuals or those with a history of liver disease.
Refrain from drinking alcohol during your Divaltec 750mg Tablet ER treatment. Combining alcohol with this medication may increase drowsiness, dizziness, or lightheadedness.
Before starting Divaltec 750mg Tablet ER, your doctor may order blood tests. These may include a complete blood count (with platelet count), bleeding time, and coagulation tests to minimize the risk of bleeding or bruising. Liver function tests are also recommended before and, especially for high-risk patients or those with a history of liver disease, during the first six months of treatment.
Severe abdominal pain, nausea, and vomiting may indicate pancreatitis. Seek immediate medical attention if you experience these symptoms. Your doctor may order a serum amylase test; if positive for pancreatitis, medication should be stopped immediately.
Divaltec 750mg ER tablet overdose can lead to headaches, blurred vision (from constricted pupils), reduced reflexes, confusion, and drowsiness. Further symptoms may include muscle weakness, seizures, unconsciousness, altered behavior, and respiratory problems like rapid breathing, shortness of breath, or chest pain. Seek immediate medical help if an overdose occurs.
Divaltec 750mg Tablet ER
124
MRP 143
13% off